NCT06599593View on ClinicalTrials.gov

Leveraging the Seasonal Malaria Chemoprevention Platform to Address Malaria and Malnutrition

NAActive, not recruitingINTERVENTIONAL
Enrollment

438

Participants

Timeline

Start Date

July 3, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

October 30, 2026

Conditions
Malaria IncidenceSeasonal Malaria ChemopreventionNutrition AssessmentAcute Malnutrition in ChildhoodAcute MalnutritionIntegrated Community-based Intervention Package
Interventions
DIETARY_SUPPLEMENT

SQ-LNS

CHW provides all children ages 6-24 months who do not have acute malnutrition with SQ-LNS (Enov'nutributter; Nutriset; 20 g/day, approximately 100-120 calories).

OTHER

Integrated Nutritional Screening

In conjunction with SMC administration, CHWs screen children for MUAC. CHW refers children with MUAC \<12.5 to the CSPS for MAM/SAM care and to receive all standard nutritional program.

Trial Locations (1)

Unknown

Centre de Recherche en Sante de Nouna, Nouna

All Listed Sponsors
collaborator

Centre de Recherche en Sante de Nouna, Burkina Faso

OTHER_GOV

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of California, San Francisco

OTHER

NCT06599593 - Leveraging the Seasonal Malaria Chemoprevention Platform to Address Malaria and Malnutrition | Biotech Hunter | Biotech Hunter